The Journal of Inherited Metabolic Disease (JIMD) is the official journal of the Society for the Study of Inborn Errors of Metabolism (SSIEM). By enhancing communication between workers in the field throughout the world, the JIMD aims to improve the management and understanding of inherited metabolic disorders. It publishes results of original research and new or important observations pertaining to any aspect of inherited metabolic disease in humans and higher animals. This includes clinical (medical, dental and veterinary), biochemical, genetic (including cytogenetic, molecular and population genetic), experimental (including cell biological), methodological, theoretical, epidemiological, ethical and counselling aspects. The JIMD also reviews important new developments or controversial issues relating to metabolic disorders and publishes reviews and short reports arising from the Society's annual symposia. A distinction is made between peer-reviewed scientific material that is selected because of its significance for other professionals in the field and non-peer- reviewed material that aims to be important, controversial, interesting or entertaining (“Extras”).

《遗传代谢病杂志》（JIMD）是先天性代谢缺陷研究学会（SSIEM）的官方杂志。通过加强全球该领域工作者之间的交流，JIMD 旨在改善对遗传性代谢疾病的管理和理解。它发表原创研究结果以及与人类和高等动物遗传性代谢疾病的任何方面相关的新发现或重要观察结果。这包括临床（医学、牙科和兽医）、生化、遗传（包括细胞遗传学、分子和群体遗传学）、实验（包括细胞生物学）、方法学、理论、流行病学、伦理和咨询方面。JIMD 还回顾与代谢疾病有关的重要新进展或有争议的问题，并发表学会年度研讨会的评论和简短报告。同行评审的科学材料因其对该领域的其他专业人士具有重要意义而被选中，而未经同行评审的材料旨在具有重要性、争议性、有趣或娱乐性（“附加内容”），两者有所区别。

该刊已被国际权威数据库SCIE收录，该刊致力于发表经过严格同行评审的高质量原创文章，反映医学-内分泌学与代谢领域的新进展、新技术、新成果，促进该领域科研交流和科研成果转化。该刊2023年影响因子为4.2，平均审稿速度为 偏慢,4-8周 ，近四年来没有被列入预警名单。如果您需要投稿发表服务及指导，可以联系我们的客服老师，我们专业专注服务期刊投稿协助10年，为您提供期刊投稿个性化定制服务，并且我们确保严格保密您的个人信息及稿件内容。